Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 1
1993 2
1994 4
1995 3
1996 2
1998 1
1999 1
2000 1
2007 2
2009 1
2010 1
2011 1
2016 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Budesonide in inflammatory bowel disease.
Lamers CB, Wagtmans MJ, van der Sluys Veer A, van Hogezand RA, Griffioen G. Lamers CB, et al. Among authors: van der sluys veer a. Neth J Med. 1996 Feb;48(2):60-3. doi: 10.1016/0300-2977(95)00090-9. Neth J Med. 1996. PMID: 8819801 Review.
Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life.
Willemse SB, Baak LC, Kuiken SD, van der Sluys Veer A, Lettinga KD, van der Meer JT, Depla AC, Tuynman H, van Nieuwkerk CM, Schinkel CJ, Kwa D, Reesink HW, van der Valk M. Willemse SB, et al. Among authors: van der sluys veer a. J Viral Hepat. 2016 Dec;23(12):950-954. doi: 10.1111/jvh.12567. Epub 2016 Jul 13. J Viral Hepat. 2016. PMID: 27405785
Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders.
Bergmann JF, Vrolijk JM, van der Schaar P, Vroom B, van Hoek B, van der Sluys Veer A, de Vries RA, Verhey E, Hansen BE, Brouwer JT, Janssen HL, Schalm SW, de Knegt RJ. Bergmann JF, et al. Among authors: van der sluys veer a. Liver Int. 2007 Nov;27(9):1217-25. doi: 10.1111/j.1478-3231.2007.01540.x. Liver Int. 2007. PMID: 17919233 Clinical Trial.
No beneficial effects of amantadine in treatment of chronic hepatitis C patients.
van Soest H, van der Schaar PJ, Koek GH, de Vries RA, van Ooteghem NA, van Hoek B, Drenth JP, Vrolijk JM, Lieverse RJ, Houben P, van der Sluys Veer A, Siersema PD, Schipper ME, van Erpecum KJ, Boland GJ. van Soest H, et al. Among authors: van der sluys veer a. Dig Liver Dis. 2010 Jul;42(7):496-502. doi: 10.1016/j.dld.2009.10.006. Epub 2009 Dec 16. Dig Liver Dis. 2010. PMID: 20018575 Clinical Trial.
Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease.
Van de Wal Y, Van der Sluys Veer A, Verspaget HW, Mulder TP, Griffioen G, Van Tol EA, Peña AS, Lamers CB. Van de Wal Y, et al. Among authors: van der sluys veer a. Aliment Pharmacol Ther. 1993 Jun;7(3):281-6. doi: 10.1111/j.1365-2036.1993.tb00099.x. Aliment Pharmacol Ther. 1993. PMID: 8364133 Clinical Trial.
Assessment of inflammatory activity in Crohn's disease.
Lamers CB, Biemond I, van der Sluys Veer A, van Hogezand RA. Lamers CB, et al. Among authors: van der sluys veer a. Neth J Med. 1994 Aug;45(2):52-4. Neth J Med. 1994. PMID: 7936005 Review.
22 results